We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.73%
5 Year Est. Return
+71.27%
10 Year Est. Return
+230.91%
AUM
$4.9B
AUM Growth
+$591M
Cap. Flow
+$151M
Cap. Flow %
3.08%
Top 10 Hldgs %
19.06%
Holding
2,548
New
83
Increased
856
Reduced
562
Closed
73

Sector Composition

Rank Sector Weight
1 Miscellaneous 73.14%
2 Technology 7.76%
3 Financials 3.6%
4 Industrials 3.55%
5 Healthcare 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
2176
Biogen
BIIB
$33.6B
$5.18K ﹤0.01%
24
+19
+380% +$3.63K
BMRN icon
2177
BioMarin Pharmaceuticals
BMRN
$11.9B
$5.15K ﹤0.01%
90
– –
SFLO icon
2178
VictoryShares Small Cap Free Cash Flow ETF
SFLO
$977M
$5.13K ﹤0.01%
+150
New +$4.88K
NXT icon
2179
Nextpower Inc. Common Stock
NXT
$12.1B
$5.12K ﹤0.01%
43
– –
HPS
2180
John Hancock Preferred Income Fund III
HPS
$398M
$5.09K ﹤0.01%
350
– –
HRB icon
2181
H&R Block
HRB
$5.27B
$5.07K ﹤0.01%
133
– –
MKC.V icon
2182
McCormick & Company Voting
MKC.V
$13.3B
$5.05K ﹤0.01%
100
– –
SLQD icon
2183
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
$5.04K ﹤0.01%
100
– –
BHE icon
2184
Benchmark Electronics
BHE
$2.95B
$5.03K ﹤0.01%
51
– –
FIS icon
2185
Fidelity National Information Services
FIS
$18B
$5.02K ﹤0.01%
129
– –
PL icon
2186
Planet Labs
PL
$6.35B
$4.97K ﹤0.01%
+150
New +$5.55K
FSTA icon
2187
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.36B
$4.95K ﹤0.01%
94
+47
+100% +$2.49K
TAP icon
2188
Molson Coors Class B
TAP
$6.84B
$4.95K ﹤0.01%
127
– –
GEM icon
2189
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.78B
$4.94K ﹤0.01%
+95
New +$4.71K
PXH icon
2190
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.06B
$4.93K ﹤0.01%
+177
New +$5.05K
TAK icon
2191
Takeda Pharmaceutical
TAK
$59.4B
$4.92K ﹤0.01%
307
– –
PBW icon
2192
Invesco WilderHill Clean Energy ETF
PBW
$357M
$4.92K ﹤0.01%
126
– –
GSIE icon
2193
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.9B
$4.89K ﹤0.01%
+107
New +$4.86K
FATE icon
2194
Fate Therapeutics
FATE
$276M
$4.86K ﹤0.01%
1,800
– –
ADC icon
2195
Agree Realty
ADC
$8.4B
$4.85K ﹤0.01%
64
+3
+5% +$227
CHTR icon
2196
Charter Communications
CHTR
$13.5B
$4.83K ﹤0.01%
34
-48
-59% -$8.01K
TDF
2197
Templeton Dragon Fund
TDF
$248M
$4.82K ﹤0.01%
443
– –
EUM icon
2198
ProShares Trust Short MSCI Emerging Markets
EUM
$12.9M
$4.8K ﹤0.01%
310
– –
BDJ icon
2199
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.69B
$4.79K ﹤0.01%
500
– –
FELV icon
2200
Fidelity Enhanced Large Cap Value ETF
FELV
$3.41B
$4.78K ﹤0.01%
119
– –

Similar funds

Geneos Wealth Management's Q2 2026 Portfolio in Review

As of Q2 2026, Geneos Wealth Management held 2,548 positions worth $4.9B, up 14% from $4.31B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $151M of net new capital in Q2 2026, opening 83 new positions and adding to 856 existing holdings. Its largest new stake was iShares MSCI Japan ETF: 20,500 shares worth $1.91M.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, up from 73% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $11.9M trimmed.

  • Geneos Wealth Management's largest Q2 2026 buy was iShares MSCI Japan ETF: 20,500 shares worth $1.91M.
  • Geneos Wealth Management added most to iShares 0-3 Month Treasury Bond ETF in Q2 2026, an estimated $22.1M increase.
  • Geneos Wealth Management's biggest Q2 2026 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $11.9M.
  • Geneos Wealth Management fully exited Honeywell in Q2 2026, selling an estimated $9.14M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $4.9B portfolio in Q2 2026.
  • Geneos Wealth Management opened 83 new positions and closed 73 in Q2 2026.
  • Geneos Wealth Management's portfolio value rose 14% quarter-over-quarter to $4.9B.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.